The PERK/ATF4 pathway drives amino acid biosynthesis in autosomal dominant polycystic kidney disease (52), and it augments antitumor activity of T cells by increasing mitophagy (53). The gene discussed is ATF4; the disease is autosomal dominant polycystic kidney disease.